Pedro Franco-Montero

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
A(2B) adenosine receptor antagonists may be beneficial in treating diseases like asthma, diabetes, diabetic retinopathy, and certain cancers. This has stimulated research for the development of potent ligands for this subtype, based on quantitative structure-affinity relationships. In this work, a new ensemble machine learning algorithm is proposed for(More)
  • 1